Cancer Cell. measured in tumors obtained from cell lines and were observed in both intracranial and subcutaneous xenografts. In conclusion, we provide the first demonstration that ADP has therapeutic potential

All authors performed analysis. (%)6 (16)0 (0)0.000339Systemic immunosuppression (apart from rituximab) granted within 3?a few months before initiation of vaccinationa, (%)18 (49)23 (24)0.0111(%)0.24?12?months11 (30)18 (19) ?12?months26 (70)81 (78)(%)Lymphocytes, (%)0.00576? ?1